Plea Bargaining in Drug Cases: Court Rules vs Executive Discretion

The Supreme Court's July 2022 decision in People v. Montierro and Baldadera settles a significant tension in Philippine criminal procedure: who gets to set the rules for plea bargaining in drug cases—the Court or the Department of Justice? The ruling affirms that plea bargaining is a matter of procedure within the Court's exclusive domain, and that executive issuances cannot override the Court's Plea Bargaining Framework in Drugs Cases.

The Cases Behind the Controversy

Two accused individuals, Erick Montierro and Cypher Baldadera, were separately charged with illegal sale of dangerous drugs under Section 5, Article II of Republic Act No. 9165. Montierro was caught with 0.721 gram of shabu, while Baldadera was arrested with only 0.048 gram.

Both sought to plead guilty to the lesser offense of possession of drug paraphernalia under the Comprehensive Dangerous Drugs Act, as allowed by the Supreme Court's Plea Bargaining Framework in Drugs Cases (A.M. No. 18-03-16-SC). The framework permits plea bargaining for Section 5 charges when the quantity involved is 0.01 to 0.99 gram of shabu.

The prosecution objected, citing Department of Justice Circular No. 27, which allowed only a plea to illegal possession of drugs under another provision of RA 9165—a far more serious offense with a penalty of 12 to 20 years. The trial courts approved the plea bargains anyway, declaring the DOJ circular an encroachment on the Court's rule-making power.

The Core Legal Issue

The central question was whether DOJ circulars could restrict plea bargaining in drug cases despite the Court's own framework. The Court answered with a firm no.

Under Section 5(5), Article VIII of the 1987 Constitution, the Supreme Court has the exclusive power to promulgate rules of pleading, practice, and procedure in all courts. The Constitution deliberately took away from Congress—and by extension, the Executive—the power to alter or supplement these rules.

Plea bargaining, the Court explained, is squarely a rule of procedure. It has been part of Philippine procedural rules since 1940, and it exists to promote the speedy disposition of cases, conserve judicial resources, and give accused persons a chance at rehabilitation.

A Moot Issue With Lasting Significance

By the time the Court decided these cases, the DOJ had already issued Circular No. 18, which amended Circular No. 27 to conform with the Court's framework. The prosecution's objections were effectively withdrawn, making the petitions technically moot.

However, the Court chose to rule anyway, citing exceptional circumstances: the constitutional issue required formulation of controlling principles, and the conflict was capable of repetition. To dismiss the cases would have been, in the Court's words, a "castration of itself in favor of the Executive."

The Court's Clear Directive

The Court reiterated that its Plea Bargaining Framework in Drugs Cases takes precedence over any DOJ circular or similar executive issuance. Trial courts must follow the framework's one-to-one correspondence between the offense charged and the acceptable plea bargain.

The framework reflects the Court's judicial notice that many drug cases involve minuscule quantities—often less than a gram—and that accused persons frequently languish in jail for years only to be acquitted on appeal due to procedural lapses by the prosecution. Allowing a plea to a lesser offense for these small-quantity cases serves both justice and docket decongestion.

Practical Takeaways

• The Court's framework governs. The Plea Bargaining Framework in Drugs Cases (A.M. No. 18-03-16-SC) prevails over any DOJ circular or executive issuance that conflicts with it.
• Small quantities qualify. For shabu, charges under Section 5 may be pleaded down to a lesser offense when the quantity is 0.01 to 0.99 gram. For marijuana, the range is 0.01 to 9.99 grams.
• Prosecutor's consent still matters. While the framework sets the allowable bargains, the prosecutor's consent remains a requirement under Rule 116 of the Rules of Court. However, that consent cannot be withheld based on an invalid executive issuance.
• Drug dependency testing. Courts may require a drug dependency test as part of the plea bargaining process, consistent with the framework's rehabilitative purpose.
• Expect compliance. Following this ruling, prosecutors should conform their plea bargaining positions to the Court's framework, not to conflicting DOJ directives.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.